These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Site-specific inhibition of integrin alpha v beta 3-vitronectin association by a ser-asp-val sequence through an Arg-Gly-Asp-binding site of the integrin. Choi Y; Kim E; Lee Y; Han MH; Kang IC Proteomics; 2010 Jan; 10(1):72-80. PubMed ID: 19882657 [TBL] [Abstract][Full Text] [Related]
3. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands. Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378 [TBL] [Abstract][Full Text] [Related]
4. Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake. Pina A; Kadri M; Arosio D; Dal Corso A; Coll JL; Gennari C; Boturyn D Chemistry; 2020 Jun; 26(33):7492-7496. PubMed ID: 32227540 [TBL] [Abstract][Full Text] [Related]
5. Cyclic RGD and Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382 [TBL] [Abstract][Full Text] [Related]
6. αvβ3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology. Dal Corso A; Pignataro L; Belvisi L; Gennari C Curr Top Med Chem; 2016; 16(3):314-29. PubMed ID: 26126915 [TBL] [Abstract][Full Text] [Related]
7. Cyclopropane pipecolic acids as templates for linear and cyclic peptidomimetics: application in the synthesis of an Arg-Gly-Asp (RGD)-containing peptide as an αvβ3 integrin ligand. Sernissi L; Petrović M; Scarpi D; Guarna A; Trabocchi A; Bianchini F; Occhiato EG Chemistry; 2014 Aug; 20(35):11187-203. PubMed ID: 25069617 [TBL] [Abstract][Full Text] [Related]
8. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
9. Novel RGD-like molecules based on the tyrosine template: design, synthesis, and biological evaluation on isolated integrins alphaVbeta3/alphaIIbbeta3 and in cellular adhesion tests. Biltresse S; Attolini M; Dive G; Cordi A; Tucker GC; Marchand-Brynaert J Bioorg Med Chem; 2004 Oct; 12(20):5379-93. PubMed ID: 15388165 [TBL] [Abstract][Full Text] [Related]
10. Development of isoxazoline-containing peptidomimetics as dual αvβ3 and α5β1 integrin ligands. Tolomelli A; Gentilucci L; Mosconi E; Viola A; Dattoli SD; Baiula M; Spampinato S; Belvisi L; Civera M ChemMedChem; 2011 Dec; 6(12):2264-72. PubMed ID: 21953988 [TBL] [Abstract][Full Text] [Related]
11. Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide. Feni L; Parente S; Robert C; Gazzola S; Arosio D; Piarulli U; Neundorf I Bioconjug Chem; 2019 Jul; 30(7):2011-2022. PubMed ID: 31243977 [TBL] [Abstract][Full Text] [Related]
12. αvβ3- or α5β1-Integrin-Selective Peptidomimetics for Surface Coating. Mas-Moruno C; Fraioli R; Rechenmacher F; Neubauer S; Kapp TG; Kessler H Angew Chem Int Ed Engl; 2016 Jun; 55(25):7048-67. PubMed ID: 27258759 [TBL] [Abstract][Full Text] [Related]
13. A molecular toolkit for the functionalization of titanium-based biomaterials that selectively control integrin-mediated cell adhesion. Rechenmacher F; Neubauer S; Mas-Moruno C; Dorfner PM; Polleux J; Guasch J; Conings B; Boyen HG; Bochen A; Sobahi TR; Burgkart R; Spatz JP; Fässler R; Kessler H Chemistry; 2013 Jul; 19(28):9218-23. PubMed ID: 23744802 [TBL] [Abstract][Full Text] [Related]
14. Integrin alphaVbeta3 targeted gene delivery using RGD peptidomimetic conjugates with copolymers of PEGylated poly(ethylene imine). Merkel OM; Germershaus O; Wada CK; Tarcha PJ; Merdan T; Kissel T Bioconjug Chem; 2009 Jun; 20(6):1270-80. PubMed ID: 19476331 [TBL] [Abstract][Full Text] [Related]
15. Probing for integrin alpha v beta3 binding of RGD peptides using fluorescence polarization. Wang W; Wu Q; Pasuelo M; McMurray JS; Li C Bioconjug Chem; 2005; 16(3):729-34. PubMed ID: 15898744 [TBL] [Abstract][Full Text] [Related]
16. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells. Wang Y; Wang X; Zhang Y; Yang S; Wang J; Zhang X; Zhang Q J Drug Target; 2009 Jul; 17(6):459-67. PubMed ID: 19527117 [TBL] [Abstract][Full Text] [Related]
17. Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin α Raposo Moreira Dias A; Pina A; Dal Corso A; Arosio D; Belvisi L; Pignataro L; Caruso M; Gennari C Chemistry; 2017 Oct; 23(58):14410-14415. PubMed ID: 28816404 [TBL] [Abstract][Full Text] [Related]
18. Cell adhesive PET membranes by surface grafting of RGD peptidomimetics. Biltresse S; Attolini M; Marchand-Brynaert J Biomaterials; 2005 Aug; 26(22):4576-87. PubMed ID: 15722127 [TBL] [Abstract][Full Text] [Related]